News & Events | Lobe Sciences Ltd.

top of page

Publications

News Releases

Light - Big Vertical_edited.jpg

Lobe Sciences and Alera Pharma Announce Notice of Allowance for Second U.S. Patent for Conjugated Psilocin™

Lobe Sciences and Alera Pharma Announce Notice of Allowance for Second U.S. Patent for Con

11/18/24

Lobe Sciences, Ltd. Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Conjugated Psilocin™

Screen Shot 2025-01-16 at 1.34.54 PM.png

10/16/24

Lobe Sciences and Alera Pharma Announce Issuance of U.S. Patent for Conjugated Psilocin™

Screen Shot 2025-01-16 at 1.34.54 PM.png

10/2/24

Light - Big Vertical_edited.jpg

An open-label; multicenter, phase 2 study of a food enriched with docosahexaenoic acid in adults with sickle cell disease

1-s2.0-S0952327823X00064-cov150h.gif

June

2023

Clinical effect of SC411 (Altemia TM) on children with sickle cell disease in the scott trial

Screen Shot 2025-01-20 at 11.09.59 AM.png

September 2020

Industry update: What is New in the Field of Therapeutic delivery?

Screen Shot 2025-01-20 at 11.13.35 AM.png

December 2017

bottom of page